Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
POINT Biopharma Global (PNT)
NASDAQ:PNT
POINT Biopharma Global (PNT) Stock Price & Analysis
44 Followers
PNT Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$5.59 - $11.13
Previous Close$9.27
Volume401.58K
Average Volume (3M)687.75K
Market Cap
$979.78M
Enterprise Value$549.74M
Total Cash (Recent Filing)$430.03M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)11.1
Beta0.77
Next Earnings
Aug 11, 2023EPS Estimate
-$0.31Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.84
Shares Outstanding105,693,356
10 Day Avg. Volume592,542
30 Day Avg. Volume687,747
Standard Deviation0.15
R-Squared0.00180
Alpha-0.00148
Financial Highlights & Ratios
Price to Book (P/B)2.08
Price to Sales (P/S)103.60
Price to Cash Flow (P/CF)-10.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.33
Enterprise Value/Gross Profit2.43
Enterprise Value/Ebitda4.73
Forecast
1Y Price Target
$14.80Price Target Upside59.65% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
POINT Biopharma Global News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
PNT FAQ
What was POINT Biopharma Global’s price range in the past 12 months?
POINT Biopharma Global lowest stock price was $5.59 and its highest was $11.13 in the past 12 months.
What is POINT Biopharma Global’s market cap?
Currently, no data Available
When is POINT Biopharma Global’s upcoming earnings report date?
POINT Biopharma Global’s upcoming earnings report date is Aug 11, 2023 which is in 69 days.
How were POINT Biopharma Global’s earnings last quarter?
POINT Biopharma Global released its earnings results on May 15, 2023. The company reported -$0.16 earnings per share for the quarter, beating the consensus estimate of -$0.316 by $0.156.
Is POINT Biopharma Global overvalued?
According to Wall Street analysts POINT Biopharma Global’s price is currently Undervalued.
Does POINT Biopharma Global pay dividends?
POINT Biopharma Global does not currently pay dividends.
What is POINT Biopharma Global’s EPS estimate?
POINT Biopharma Global’s EPS estimate is -$0.31.
How many shares outstanding does POINT Biopharma Global have?
POINT Biopharma Global has 105,693,360 shares outstanding.
What happened to POINT Biopharma Global’s price movement after its last earnings report?
POINT Biopharma Global reported an EPS of -$0.16 in its last earnings report, beating expectations of -$0.316. Following the earnings report the stock price went up 9.833%.
Which hedge fund is a major shareholder of POINT Biopharma Global?
Among the largest hedge funds holding POINT Biopharma Global’s share is Baker Bros Advisors LP. It holds POINT Biopharma Global’s shares valued at 8M.
---
POINT Biopharma Global Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$14.80 (59.65% Upside)
$14.80 (59.65% Upside)
Blogger Sentiment
Bullish
PNT Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 355.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $125.0K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
11.55%
12-Months-Change
Fundamentals
Return on Equity
27.60%
Trailing 12-Months
Asset Growth
120.78%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
POINT Biopharma Global
Therapeutics Acquisition Corp is a blank check company.
---
Top 5 ETFs holding PNT
Vanguard Health Care ETF
$1.74M
iShares Core S&P Total U.S. Stock Market ETF
$915.27K
Fidelity MSCI Health Care Index ETF
$336.02K
iShares Russell 3000 ETF
$244.47K
Vanguard U.S. Momentum Factor ETF
$78.80K
Up to five ETFs with an Outperform Smart Score that hold PNT. The ETFs are listed according to market value of PNT within the ETF
---
---